By Dan Rivoli ( June 28, 2011, 9:19 PM EDT) -- The authors of 13 industry-sponsored studies on Medtronic Inc.'s bone-growth device Infuse downplayed serious risks related to the product and failed to adequately — if at all — disclose their financial ties with the manufacturer, a study published Tuesday said....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.